Plus Therapeutics provided highlights regarding Leptomeningeal Metastases acquisition and topline clinical trial data on the FORESEE Trial on this morning’s investor call.
Listen to the Replay: https://edge.media-server.com/mmc/p/nor9kmxs/
Highlights: https://bit.ly/4dB1tHg
Recent Comments